MOLLY MCELROY: Open Payments
NPI 1033679774 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 96 payments from 21 companies in 2025. Trend: 2023 $378 · 2024 $1,413 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $404 |
| Janssen Biotech, Inc. | 11 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $202 |
| Aimmune Therapeutics, Inc. | 8 | $175 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| Madrigal Pharmaceuticals | 3 | $67 |
| PFIZER INC. | 3 | $65 |
| Lilly USA, LLC | 3 | $61 |
| Abbott Laboratories | 2 | $59 |
Products named: TREMFYA, RINVOQ, ZENPEP, ENTYVIO, DUPIXENT, LINZESS, XIFAXAN, SKYRIZI.
Industry payments across NC — which companies pay providers there.
